Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-05
1998-06-09
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
424426, 424 851, 424520, 530356, 514 21, A61K 3808, A23J 110, C08H 106
Patent
active
057633991
ABSTRACT:
A composition and method are provided that are effective in revitalizing scar tissue by introducing a bioactive substance having angiogenic activity into the scar tissue. The bioactive substance can be introduced by itself, or it can be introduced into the scar tissue in a timed release form. The present invention is effective in treating stress urinary incontinence or localized muscular dysfunction.
REFERENCES:
patent: Re33375 (1990-10-01), Luck et al.
patent: 4061731 (1977-12-01), Gottleib
patent: 4167945 (1979-09-01), Gottlieb
patent: 4191751 (1980-03-01), Gottlieb
patent: 4582640 (1986-04-01), Smestad et al.
patent: 4703108 (1987-10-01), Silver et al.
patent: 4760131 (1988-07-01), Sundsmo et al.
patent: 4774091 (1988-09-01), Yamahira et al.
patent: 4810693 (1989-03-01), Pickart
patent: 4840940 (1989-06-01), Sottiurai
patent: 4849141 (1989-07-01), Fujioka et al.
patent: 4861757 (1989-08-01), Antoniades et al.
patent: 4952403 (1990-08-01), Vallee et al.
patent: 4952404 (1990-08-01), Vallee et al.
patent: 4970298 (1990-11-01), Silver et al.
patent: 5162430 (1992-11-01), Rhee et al.
patent: 5196185 (1993-03-01), Silver et al.
patent: 5258028 (1993-11-01), Ersek
"Wound Repair" by Jeffrey M. Davidson in Inflammation: Basic Principles and Clinical Correlation, 2nd ed., Raven Press, 1992 pp. 809-819.
Benharroch, D., et al., "Biology of the Fibrblast Growth Factor Gene Family," ISR. J. Med. Sci., vol. 26, pp. 212-219 (Apr. 1990).
Clark, R.A., "Cutaneous Tissue Repair: Basic Biologic Considerations," J. Am. Academy Dermat., vol. 13, pp. 701-725 (Nov. 1985).
Cooper, M.L., et al., "Use of a Composite Skin Graft Composed of Cultured Human Keratinocytes and Fibroblasts and a Collagen-GAG Matrix to Cover Full-Thickness Wounds on Athymic Mice," Surgery, vol. 109, pp. 198-207 (Feb. 1991).
Fajardo, L.F., et al., "Methods in Laboratory Investigation: The Disc Angiogenesis System," Lab. Invest. vol. 58, 718-724 (Jun. 1988).
Gore, D.C., et al., "Effect of Exogenous Growth Hormone on Whole-Body and Isolated-Limb Protein Kinetics in Burned Patients," Arch. Surg., vol. 126, pp. 38-43 (Jan. 1991).
Grotendorst, G.R., et al., "EGF and TGF-alpha are Potent Chemoattractants for Endothelial Cells and EGF-like Peptides and Present at Site of Tissue Regeneration," J. Cell Physio., vol. 139, pp. 617-623 (Jun. 1989).
Hansson, H.A., et al., "Transient Expression of Insulin-Like Growth Factor I Immunoreactivity by Vascular Cells During Angiogenesis," Exp. Mole. Path., vol. 50, pp. 125-138 (Feb. 1989).
Hockel, M., et al., "Purified Monocyte-Derived Antiogenic Substance (Angiotropin) Induces Controlled Angiogenesis Associated with Regulated Tissue Proliferation in Rabbit Skin," J. Clin. Invest., vol. 82, pp. 1075-1090 (Sep. 1988).
Knighton, D.R., et al., "Wound Healing Angiogenesis: Indirect Stimulation by Basic Fibroblast Growth Factor," J. Trauma, vol. 30, pp. 134-144 (Dec. 1990).
Laato, M., "Effect of Epidermal Growth Factor (EGF) on Blood Flow and Albumin Extravasation in Experimental Granulation Tissue," Acta Chir. Scand., vol. 152, pp. 401-405 (1986).
Mahadevan, V., et al., "Facotrs Influencing Blood Supply in Wound Granuloma Quantitated by New in Vivo Technique," Cancer Res., vol. 49, pp. 415-419 (Jan. 15, 1989).
Pierce, G.F., et al., "Platelet-derived Growth Factor (BB Homodimer), Transforming Growth Factor-.beta.1, and Basic Fibroblast Growth Factor in Dermal Wound Healing," Am. J. Path., vol. 140, No. 6, pp. 1375-1388 (Jun. 1992).
Qian, J.J., et al., "Increased Cell Attachment, Migration and Differentiation on Hydroxyapatite in the Presence of a Collagen-Analog," Transactions of the Society for Biomaterials, 216 (1994).
Reilly, W., et al., "Matrix Control of Tumer Angiogenesis," Adv. Exp. Med. and Biol., vol. 242, pp. 211-227 (1988).
Savage, K., Ph.D., "The Effect of Platelet-Derived Growth Factor on Cell Division and Glycosaminoglycan Synthesis by Human Skin and Scar Fibroblasts," The J. Invest. Derm., vol. 89, pp. 93-99 (1987).
Tsuboi, R., et al., "Recombinant Basic Fibroblast Growth Factor Stimulates Wound Healing In Healing-Impaired db/db Mice," J. Exp. Med., vol. 172, pp. 245-252 (Jul. 1990).
Valettte, G., et al., "Une Nouvelle Methode d-Assai Des Traitments Cicatrisant FondeSur La Mise En Oeuvre D'une Plaie Experimentals Dont La Cicatrisation Est Artificiellement Pertubee Par Hyperstimulation Locale Du Tissue De Granulation," Arzneimittelforschung, vol. 19, No. 7, pp. 1121-1132 (1969).
Van Brunt, J. et al., "Growth Factors Speed Wound Healing," Bio/Technology, vol. 6, No. 1, pp. 25-30 (1988).
C.R. Bard Inc.
Touzeau P. Lynn
Tsang Cecilia J.
LandOfFree
Composition and method for revitalizing scar tissue does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method for revitalizing scar tissue, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for revitalizing scar tissue will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2199125